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Phosphatidylinositol polyphosphate binding to the mammalian
septin H5 is modulated by GTP
Jianshe Zhang*, Chen Kong*, Hong Xie*, Peter S. McPherson†, 
Sergio Grinstein* and William S. Trimble*
Background: Septins are members of a conserved family of GTPases found in
organisms as diverse as budding yeast and mammals. In budding yeast, septins
form hetero-oligomeric filaments that lie adjacent to the membrane at the
mother–bud neck, whereas in mammals, they concentrate at the cleavage
furrow of mitotic cells; in both cases, septins provide a required function for
cytokinesis. What directs the location and determines the stability of septin
filaments, however, remains unknown. 
Results: Here we show that the mammalian septin H5 is associated with the
plasma membrane and specifically binds the phospholipids phosphatidylinositol
4,5-bisphosphate (PtdIns(4,5)P2) and phosphatidylinositol 3,4,5-trisphosphate
(PtdIns(3,4,5)P3). Deletion analysis revealed that this binding occurs at a site
rich in basic residues that is conserved in most septins and is located adjacent
to the GTP-binding motif. Phosphoinositide binding was inhibited by mutations
within this motif and was also blocked by agents known to associate with
PtdInsP2 or by a peptide corresponding to the predicted PtdInsP2-binding
sequence of H5. GTP binding and hydrolysis by H5 significantly reduced its
PtdInsP2-binding capability. Treatment of cells with agents that occluded,
dephosphorylated or degraded PtdInsP2 altered the appearance and
localization of H5.
Conclusions: These results indicate that the interaction of septins with
PtdInsP2 might be an important cellular mechanism for the spatial and temporal
control of septin accumulation.
Background
Septins are a family of proteins that were first identified
in yeast as being required for the completion of the cell
cycle [1–3]. Four septin proteins in the budding yeast
Saccharomyces cerevisiae, CDC3, CDC10, CDC11 and
CDC12, were all identified in mutants defective in the
cell cycle that had a similar phenotype, namely abnor-
mally elongated buds unable to complete cytokinesis [4].
Mutations in each of the genes encoding these proteins
also disrupt a characteristic set of filaments, which
closely associate with the plasma membrane in a series of
concentric rings around the mother–bud neck [5,6].
Coupled with immunocytochemical studies, these obser-
vations indicate that septins form hetero-oligomeric fila-
ments that contribute to bud-site selection and neck
stability (reviewed in [2,3]). Demonstration that the
Drosophila melanogaster cytokinesis mutation peanut occurs
in a septin protein revealed that animal cells undergoing
fission also require septins for this process [7]. Like
yeast, Drosophila also have multiple septin isoforms,
including Sep1 [8] and Sep2, which appear to assemble
into hetero-oligomeric filaments [9] required for the
completion of cytokinesis. 
Ten septin isoforms have been identified to date in
mammals. These are Nedd5 [10], hCDC10 [11], KIAA0128
[12], KIAA0202 [13], Diff6 [14], hCDCrel-1/PNUTL1
[15,16], eSEP [17], G-SEP (GenBank accession number
AF111179), KIAA0991 [18] and H5 [19]. Most of these
were identified through random sequencing strategies, sub-
tractive screens or as candidate genes within disease loci.
All septins share in common the presence of a GTP-
binding domain near the amino terminus and almost all
contain a predicted coiled-coil motif near the carboxyl ter-
minus of the protein. The mammalian isoforms share
between 41% and 76% amino acid sequence identity, with
highest identity in the GTP-binding domain. 
With the exception of Nedd5, very little is known about
the function of mammalian septins. Nedd5 is broadly
expressed and has been shown to concentrate at the cleav-
age furrow of mitotic cells. Mutations that prevent this
protein from binding GTP disrupt its filamentous appear-
ance in interphase cells. Microinjection of antibodies to
Nedd5 impairs cytokinesis, as shown by the accumulation
of multinucleated cells [20]. H5 is less well characterized
but has many properties in common with Nedd5. We have
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found that, in contrast to initial predictions based on its
isolation from brain, H5 is also broadly expressed, with
highest expression levels in the nervous system and signif-
icant expression levels in most tissues [21]. 
Preliminary fractionation studies have shown that both
Nedd5 and H5 associate predominantly with membranes
[21]. The mechanism underlying this association is
obscure, because septins lack transmembrane domains
and other obvious membrane-localization motifs. As an
initial approach to establish how septins associate with
membranes, we determined whether H5 could associate
directly with phospholipids. Here, we show that H5 binds
directly to phosphatidylinositol (4,5) bisphosphate
(PtdIns(4,5)P2) and phosphatidylinositol (3,4,5) trisphos-
phate (PtdIns(3,4,5)P3) but not to a variety of other phos-
pholipids including PtdIns(3,4)P2. This interaction was
found to occur at a site adjacent to the GTP-binding
domain of H5 that is rich in lysine residues and similar to
the PtdInsP2-binding motifs found in several other pro-
teins. Association of H5 with GTP decreased its binding
to PtdIns(4,5)P2, suggesting that functional interactions
occur between its nucleotide-binding and lipid-binding
domains. In cells treated with agents that block or hydro-
lyse PtdInsP2, H5 filaments were reduced and cytokinesis,
a cellular process requiring septin function, was blocked.
These results suggest that PtdIns(4,5)P2 and/or
PtdIns(3,4,5)P3 might be important in regulating septin
localization and function. 
Results
In yeast, septins appear to be tightly associated with the
membrane of the mother–bud neck [5]. Our preliminary
biochemical fractionation studies also suggest an associa-
tion of mammalian septins with membranes [21]. To
investigate the nature of this association, we examined the
ability of the septin H5 to bind directly to membrane
phospholipids. To this end, we used an enzyme-linked
immunoabsorbent assay (ELISA) in which phospholipids
were dried on solid substrates and incubated with recom-
binant H5 expressed as a glutathione-S-transferase (GST)
fusion protein [22]. To control for nonspecific interactions,
GST alone was also incubated with the phospholipids.
Bound protein was detected by probing for the presence
of GST with antibodies. As shown in Figure 1a, GST–H5
bound significantly better to PtdIns(4,5)P2 than to phos-
phatidylinositol (4)monophosphate (PtdIns(4)P), phos-
phatidylinositol (PtdIns), phosphatidylcholine (PtdCho) or
phosphatidylserine (PtdSer). GST alone bound very
poorly to all of the lipids tested.
Dried lipids on a solid substrate might not represent the
configuration of lipids found in biological membranes.
Therefore, to more faithfully reconstitute the lipid environ-
ment of a membrane, and to further define the specificity of
lipid binding to H5, we performed binding experiments
using a liposome sedimentation assay [23]. As the ELISA
assays suggested that H5 bound only marginally to PtdCho,
we generated mixed liposomes containing 95% PtdCho and
5% of either PtdIns(3,4)P2, PtdIns(4,5)P2 or PtdIns(3,4,5)P3.
After incubation with recombinant H5, the liposomes were
sedimented and the distribution of the protein between
pellet and supernatant fractions was assessed by
immunoblotting. As shown in Figure 1b, significant
amounts of H5 associated with liposomes  containing
PtdIns(4,5)P2 or PtdIns(3,4,5)P3, but not with those com-
posed of PtdCho alone or PtdCho and PtdIns(3,4)P2.
The affinity of H5 for PtdIns(4,5)P2 was also estimated
using the sedimentation assay described above. A represen-
tative example is shown in Figure 2a and demonstrates that,
when increasing concentrations of PtdIns(4,5)P2 were
included in the liposome mixture, the efficiency of H5 sedi-
mentation increased proportionally. When the results of
three independent experiments were quantified
(Figure 2b), we found that H5 bound to PtdIns(4,5)P2 with
an apparent dissociation constant of approximately 10 µM. 
PtdInsP2 has been observed to interact with proteins con-
taining pleckstrin homology (PH) domains, often promot-
ing their association with the membrane [24]. Perusal of
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Figure 1
Binding of PtdInsP2 to the septin H5. (a) H5 binds to PtdIns(4,5)P2
but not to several other phospholipids. An aliquot (1 µg) of
PtdIns(4,5)P2, PtdIns(4)P, PtdIns, PtdSer or PtdCho was dried onto an
ELISA plate, washed extensively and then incubated with buffer
containing either 1 µg GST or 1 µg of a fusion protein comprising GST
and full-length H5 (H5). Bound proteins were detected with an
anti-GST antibody and measured by ELISA using a secondary
antibody conjugated with horseradish peroxidase. Quantitation of
bound protein was determined by measuring absorbance at 450 nm.
Values shown are the means ± standard errors (SEs) from triplicate
experiments. (b) H5 specifically binds to PtdIns(4,5)P2 and
PtdIns(3,4,5)P3. A liposome sedimentation assay was used in which
30 µg of liposomes comprising 95% PtdCho and 5% of the indicated
lipid were incubated with 1 µg H5 protein, then centrifuged to
separate the bound (pellet) protein from the unbound (supernatant).
Western blots were performed for each fraction from three
independent experiments and quantified by densitometry.
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the sequence of the septin H5 failed to reveal sequences
related to PH domains, however. Nevertheless, PtdInsP2
binding has also been demonstrated in many proteins
lacking PH domains, suggesting that other protein motifs
might also confer this property. A deletion analysis of gel-
solin was the first to demonstrate that PtdInsP2 can bind
to sequences rich in basic amino acids, and that this
binding is specific [25–30]. Like many other highly
charged proteins, H5 contains a number of motifs that
have a polybasic nature similar to the PtdInsP2-binding
site found in gelsolin. To determine whether any of these
motifs were responsible for PtdInsP2 binding by H5, we
generated a series of GST–H5 constructs expressing suc-
cessively truncated versions of the protein. Each of these
constructs yielded stable proteins when expressed in bac-
teria, and the resulting purified proteins stained with
Coomassie Brilliant Blue are shown in Figure 3a. For
construct ∆452, in which the H5 protein was truncated
after amino acid 452, a faint contaminating product was
occasionally observed at the molecular weight of the full-
length protein. This is, however, an immunologically
unrelated product of unknown origin, as shown by
western blot analysis (Figure 3b). As shown in Figure 3b,
each of the truncated proteins reacted with an antibody
raised to the amino terminus of H5, as would be expected
given that even the shortest fragment contains the
immunogenic motif.
Each truncation product was then used in PtdInsP2-
binding ELISA assays similar to those shown in
Figure 2a. As shown in Figure 3c, PtdIns(4,5)P2 bound
to all of the truncation mutants except ∆112, indicating
that the binding site must reside between amino acids
112 and 230. Within these 118 residues lies a highly
basic sequence between amino acids 135 and 141 that is
very similar to polybasic sequences found in gelsolin and
in members of the GRK4/5/6 family [26,29]. Related
poly-basic sequences are found at the same location in
septins from Drosophila and yeast, and in almost all of
the mammalian septins (Figure 4a) [2].
To determine whether this polybasic sequence is indeed
capable of binding PtdInsP2, a synthetic peptide was pro-
duced that corresponded to this region of the protein, and
an unrelated sequence within H5 was used as a control.
Various concentrations of these peptides were then immo-
bilized on the surface of the ELISA plate and PtdInsP2
binding was measured as before. As shown in Figure 4b, the
peptide corresponding to the polybasic region (PEP1)
bound PtdInsP2 avidly, whereas the control peptide (PEP2)
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Figure 3
Deletion mapping of the PtdIns(4,5)P2-binding site on H5. A series of
carboxy-terminal truncations were constructed in the H5 coding
sequence and expressed as GST fusion proteins. In each case, the
name of the truncated protein represents the amino acid at which the
protein terminated. (a) Purified GST–H5 and truncation mutants
stained with Coomassie Brilliant Blue. Equivalent masses of fusion
protein were electrophoresed and stained to demonstrate purity and
stability of truncated forms. (b) Western blotting of truncated forms.
Equal concentrations of GST–H5 and truncated proteins were
electrophoresed, blotted and probed with an antibody generated
against a peptide identical to amino acids 29–48 of H5. This peptide
sequence is present in all truncated forms. (c) Binding of PtdIns(4,5)P2
to truncated forms. ELISA was used to assay the binding of 1 µg
PtdInsP2 to 1 µg of each truncated protein, as described in Figure 2a.
PtdIns(4,5)P2 binding was unaffected until the carboxy-terminal
truncations reached amino acid 112. Values represent the mean ± SE
from triplicate experiments.
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Figure 2
Saturable binding of H5 to PtdIns(4,5)P2.
(a) Western blot of a liposome sedimentation
assay in which increasing concentrations of
PtdIns(4,5)P2 were used. Liposomes
comprising PtdCho and increasing
concentrations of PtdIns(4,5)P2, as indicated,
were incubated with 1 µg H5, then centrifuged
to separate the bound (pellet) protein from the
unbound (supernatant). (b) Quantitation of the
sedimentation assays shown in (a). Western
blots were performed for the pellet fractions
from three independent experiments and
quantified by densitometry. Values represent
the mean ± SE from triplicate experiments.
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failed to bind. To determine whether the peptide could
also bind to PtdInsP2 in solution, an inhibition assay was
performed. In this case the peptides, or other binding
inhibitors, were mixed with the PtdInsP2 micelles before
their exposure to the immobilized full-length GST–H5
protein. To confirm that this assay could detect competitive
inhibition, known antagonists of PtdInsP2 binding were
used. As shown in Figure 4c, both pentalysine [31–33] and
neomycin [34] were effective at inhibiting the interaction of
PtdInsP2 with H5. The polybasic peptide (PEP1) also com-
pletely blocked the binding of PtdInsP2 to H5, whereas a
comparable concentration of the control peptide had no
effect. Together, these results indicate that the polybasic
sequence found between residues 135 and 141 of H5 is an
efficient binding site for PtdIns(4,5)P2.
We next used site-directed mutagenesis to demonstrate
that the region encompassed by residues 135 and 141
was necessary for binding of PtdIns(4,5)P2 to H5. Two
different mutants were generated that converted pairs of
basic amino acids to alanine residues, as shown in
Figure 5a. Recombinant GST–H5 proteins containing
these mutations were then immobilized on plates and
used in an ELISA micellar assay, as described in
Figure 2a, to quantify PtdIns(4,5)P2 binding to the wild
type and mutant forms of H5. As seen in Figure 5b,
mutation of the arginine and lysine residues at positions
136 and 137 (mutation 1) had only a modest effect on the
binding, whereas replacement of the lysines at positions
140 and 141 (mutation 2) ablated binding. The liposome
sedimentation assay was used to compare the relative
effects of the mutations on binding to PtdIns(4,5)P2 and
PtdIns(3,4,5)P3. In accordance with the ELISA assay, the
amount of H5-mutation 2 found to associate with
PtdIns(4,5)P2 was markedly reduced, whereas the
Research Paper  PtdInsP2 binding to the septin H5 Zhang et al. 1461
Figure 4
A polybasic region in H5 can bind PtdIns(4,5)P2. (a) Alignment of
known septins reveals conservation of a polybasic motif near the
P-loop sequence. Amino acid sequences of known mammalian (top
group), Drosophila (middle group) and S. cerevisiae (bottom group)
septins is shown. Aligned regions are indicated by amino acid numbers
to the left and right. Identical amino acids are white on a black
background, whereas those on a grey background are similar. The
proximity of the polybasic and P-loop motifs are indicated above.
Comparable polybasic motifs from gelsolin and GRK5 are indicated
below. (b) A peptide derived from amino acids 136–149 (PEP1) but
not a control peptide (PEP2) bound PtdIns(4,5)P2 directly. ELISA wells
coated with increasing amounts of PEP1, as indicated, displayed high
PtdIns(4,5)P2-binding capability, whereas wells coated with the same
amount of PEP2 showed little if any binding. (c) The H5 polybasic
sequence is an effective inhibitor of PtdIns(4,5)P2 binding. Competitive
inhibition of PtdIns(4,5)P2 binding was performed by premixing the
PtdIns(4,5)P2 micelles with the indicated inhibitors before incubation
with the immobilized GST–H5 or GST protein. PEP1 was as effective
in competing for PtdIns(4,5)P2 binding as the known
PtdIns(4,5)P2-binding agents pentalysine (lys5) and neomycin (neo).
Values represent the mean ± SE from triplicate experiments.
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Figure 5
Distinct residues are important for PtdIns(4,5)P2 and PtdIns(3,4,5)P3
binding. (a) Site-directed mutagenesis strategy. Two mutations were
generated that substituted alanine residues for residues 136 and 137
(mutation 1) or residues 140 and 141 (mutation 2). (b) PtdIns(4,5)P2
binding is impaired by mutation 2. Using an ELISA assay, the amount
of micellar PtdIns(4,5)P2 bound to immobilized wild-type H5 or to the
mutant proteins is shown. Values represent the mean ± SE from
triplicate experiments. (c) Differential effects of mutations on
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 binding. Liposomes comprising
PtdCho alone, or 95% PtdCho and 5% of either PtdIns(4,5)P2 or
PtdIns(3,4,5)P3 were incubated with wild-type H5 or H5 mutants, then
sedimented as described in the Materials and methods. The pellets
were blotted for bound H5 protein and triplicate experiments were
quantified. Binding of wild-type H5 to liposomes comprising 100%
PtdCho was used as a control and is shown in the first lane (n = 6).
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binding of H5-mutation 1 was intermediate (Figure 5c).
In surprising contrast, binding of PtdIns(3,4,5)P3 was not
affected by mutation 2, but was significantly reduced by
mutation 1, implying that distinct amino acids contribute
to the binding of each lipid.
The proximity of the PtdInsP2-binding motif to the GTP-
binding P-loop raised the interesting possibility that
PtdInsP2 binding might influence the ability of H5 to bind
or hydrolyze the nucleotide. In order to test this hypothe-
sis, we measured [γ-32P]GTP binding to the septin using
the assay of Kinoshita et al. [20], in the presence or
absence of PtdIns(4,5)P2. Binding assays were performed
by incubating GST–H5 or GST alone, bound to glu-
tathione–agarose beads, with [γ-32P]GTP at 0°C in the
presence of EDTA to prevent hydrolysis. After washing,
the amount of radioactivity associated with the beads was
measured. As shown in Figure 6a, H5 bound significantly
more [γ-32P]GTP than the GST control but this binding
was not influenced by the presence of PtdInsP2. To
measure hydrolysis of the nucleotide, beads treated in the
same way were then washed with buffer containing Mg2+
but no EDTA, and warmed to 37°C. Hydrolysis leads to
removal of the γ-phosphate from GTP with attendant loss
of radioactivity from the beads. To prove that the loss of
32P from the beads was due to hydrolysis and not dissocia-
tion, control samples were maintained for 20 min in either
hydrolysis buffer at 0°C or in loading buffer at 37°C.
Neither condition showed significant loss of 32P during
this period (data not shown). As shown in Figure 6a, com-
plete hydrolysis of the bound GTP had occurred within
5 minutes either in the presence or absence of
PtdIns(4,5)P2, suggesting that within the limits of detec-
tion of this assay, PtdIns(4,5)P2 had no effect on either the
ability of H5 to bind or to hydrolyze GTP. 
We next tested whether the inverse relationship existed,
namely, whether PtdInsP2 binding might itself be
affected by binding of nucleotides to H5. To test this
possibility, PtdIns(4,5)P2 binding to H5 was analyzed
using the liposome sedimentation assay. Liposomes were
mixed with recombinant proteins that had been pre-incu-
bated with the indicated nucleotides. As shown in
Figure 6b, GDP and GDPβS had no significant effect on
H5 binding. In contrast, GTPγS significantly reduced the
amount of H5 found in the pellet. Most surprising was
the reduction in binding found when H5 was bound to
GTP. In this case, the vast majority of the H5 failed to
bind to the liposomes. Together, these observations indi-
cate that the association of H5 with PtdIns(4,5)P2 is influ-
enced by the nucleotide to which the septin is bound.
Furthermore, as GTP inhibited binding more than
GTPγS, this suggests that hydro-lysis of GTP might
result in membrane dissociation.
If PtdInsP2 is involved in modulating the association of
H5 with the membrane and if this association is essential
for its function, it should be possible to interfere with
septin function in vivo by precluding its binding to
PtdInsP2 using competing compounds. Neomycin is
known to permeate cell membranes slowly and to block
PtdInsP2 interactions with proteins. To evaluate whether
competitive displacement of PtdInsP2 would affect the
location or filamentous appearance of H5, cells were incu-
bated in 5 mM neomycin sulfate for various time periods,
then fixed and immunostained with antibodies specific to
H5. Consistent with earlier observations [35], neomycin
treatment resulted in disruption of actin stress fibers from
the central part of the cell, whereas peripheral fibers and
cortical actin networks appeared unaffected (Figure 7).
H5 filaments were also disrupted, causing the H5
immuno-reactivity to appear dispersed, with some con-
centrations near the edges of the plasma membrane. 
Septin proteins have been shown in many species to have
a requisite function in cytokinesis [4,6,7,20]. In Drosophila
lacking the septin protein Peanut, developing tissues
accumulate multinucleated syncytia, indicating inhibition
of cytokinesis [7]. In mammalian cells, transfection of
mutated Nedd5 proteins that are inhibited in GTP-binding
1462 Current Biology Vol 9 No 24
Figure 6
(a) Binding and hydrolysis of GTP by H5 are not affected by
PtdIns(4,5)P2. Glutathione–agarose beads bound with either GST,
GST–H5 or GST–H5 and PtdIns(4,5)P2 were incubated with
[γ-32P]GTP on ice, then washed, resuspended in hydrolysis buffer and
immediately assayed for bound [γ-32P]GTP (0 min), or incubated for 5
or 20 min at 37°C before quantitation. Values represent the mean ± SE
from quadruplicate experiments. (b) PtdIns(4,5)P2 binding is reduced
when H5 is in its GTP-bound form. Using the sedimentation assay
described in Figure 1b, liposomes comprising PtdCho and
PtdIns(4,5)P2 at a ratio of 95:5 were prepared and mixed with 0.8 µg
of freshly prepared GST–H5 protein that had previously been
incubated with the indicated nucleotide (1 mM final concentration) for
30 min at room temperature. After mixing, the samples were incubated
for a further 60 min at room temperature before centrifugation at
50,000 × g for 40 min. The supernatants and pellets from each sample
were electrophoresed, blotted and probed for H5. The results shown
are from three independent experiments. The control indicates the
binding of wild-type H5 to liposomes comprising 100% PtdCho. 
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disrupt the filamentous appearance of endogenous Nedd5
in interphase cells and injection of antibodies to Nedd5
led to binucleated cells through failure in cytokinesis [20].
In this study, we found that as many as 10% of the cells in
the cultures treated with neomycin became binucleated,
indicative of impaired cytokinesis (Figure 7i). In control
cultures, binucleated cells were very rarely observed.
An alternative means to interfere with PtdInsP2 availability
in the cell is to reduce the overall levels of the phospho-
lipid by transient transfection of the cells with the phos-
phatidylinositol 5-phosphatase synaptojanin [36]. A cDNA
encoding synaptojanin was subcloned into the mammalian
expression vector pcDNA3.1 and co-transfected into cells
along with an enhanced green fluorescence protein (GFP)
reporter plasmid (pEGFP). As before, indirect immuno-
fluorescence was used to monitor the effects of synapto-
janin expression on H5. As can be seen in Figure 8,
GFP-positive cells contained significantly fewer actin
stress fibers than untransfected control cells and, as in the
case of cells treated with neomycin, the remaining fibers
were displaced to the edge of the cell. This is consistent
with previous studies in which synaptojanin was trans-
fected into COS-7 cells [36]. In all GFP-positive cells, the
filamentous appearance of H5 was disrupted and H5
appeared punctate. Occasionally, GFP-positive cells were
found to be binucleated (data not shown), although at a
lower frequency than in neomycin-treated cells.
As a third and more acute approach to interfere with the
availability of PtdInsP2, cells were treated with iono-
mycin in the presence of extracellular calcium to activate
phospholipase C (PLC) [37]. In order to monitor
PtdIns(4,5)P2 levels during this treatment, cells were
transiently transfected with a construct containing a
fusion between the PH domain of phospholipase C-δ
and GFP. This chimeric protein associates with PtdInsP2
and has been used as an accurate index of the amount of
this phospholipid present in intact cells [37]. In cells
expressing moderate levels of the PH-domain–GFP
chimera, the majority of the fluorescence was detected
near the plasma membrane. Following activation of PLC
by treatment with ionomycin for 10 minutes, the GFP
construct shifted from the plasma membrane to the cyto-
plasm (data not shown). As seen in Figure 9, the H5 fila-
ments were disrupted in cells treated with ionomycin,
whereas actin stress fibers were only moderately
reduced. Similar results were obtained in cells stained
with antibodies to the septin Nedd5 (data not shown).
Hence, the filamentous appearance of septins requires
the continued presence of PtdInsP2 and/or PtdInsP3
within the cells and is not solely dependent on the fila-
mentous appearance of actin. 
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Figure 7
Neomycin disrupts H5 filaments and
produces multinucleated cells. Swiss 3T3
cells grown to logarithmic phase in DMEM
containing 10% fetal bovine serum were
incubated for an additional 2 h in medium
either with or without 5 mM neomycin sulfate.
Cells were then fixed and processed for
immunocytochemistry and triple-labeled with
DAPI, FITC-conjugated phalloidin and primary
rabbit antibodies to H5, which were detected
with Cy3-conjugated goat anti-rabbit
antibodies. (a–c) Control cells reflect the
normal actin and H5 staining patterns in
Swiss 3T3 cells. (d–i) Neomycin-treated cells
have (e,h) dispersed H5 filaments, (d,g) loss
of actin stress fibers, and (f,i) binucleation.
(g–i) Lower magnification views demonstrate
the high frequency of binucleation. The scale
bar in (c,f,i) represents 10 µm.
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Actin H5 DAPI
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While monitoring the effectiveness of the treatment with
ionomycin, we noted that expression of the PH-
domain–GFP chimera affected the distribution of H5.
Even low levels of the chimera were sufficient to disrupt
H5 filaments (data not shown), reminiscent of the chela-
tion of PtdInsP2 observed with neomycin (Figure 7). We
believe that such disruption results from association of
the chimera with PtdInsP2, causing displacement of the
septin from the membrane.
Discussion
The demonstration that the septin H5 binds directly and
specifically to PtdIns(4,5)P2 and PtdIns(3,4,5)P3 provides
the first insights into the possible signaling mechanisms
that lead to filament-like accumulations of septins. H5 and
several other mammalian septins contain a polybasic
sequence similar to those of a variety of PtdInsP2-binding
proteins. Here, we have shown that this motif is capable of
specific interactions with PtdInsP2. Polybasic PtdInsP2-
binding sites were first identified in the actin-severing
protein gelsolin [26] and later in a variety of proteins,
including profilin [27,30], G-protein-coupled receptor
kinases [29], inward rectifying potassium channels and
Na+–Ca2+ exchangers [28]. In general, these sequences are
rich in lysine and arginine, and bind PtdInsP2 with a lower
affinity than has been observed for PH domains. This sug-
gests that other residues within the motif also contribute
to secondary structures that enhance the binding affinity.
For example, the protein mSOS1 has both a PH domain
and a polybasic motif. The former was found to bind with
a Kd of 1.8 µM whereas the latter had a Kd of 53 µM [23].
The apparent Kd of PtdIns(4,5)P2 binding to H5 was
10 µM, reflecting a lower binding affinity than a typical
PH domain but higher than that of the related polybasic
site in mSOS1.
Both the location and charge distribution of the PtdInsP2-
binding site identified in H5 are highly conserved
Figure 9
Ionomycin treatment causes rapid dissociation of H5 filaments. Swiss
3T3 cells were incubated in Dulbecco’s MEM in the presence of 2 µM
ionomycin for 10 min. (a,b) The actin and H5 patterns of untreated
cells, respectively. (c,d) The effect of ionomycin treatment.
(a) (b)
(c) (d)
Actin H5
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Figure 8
Expression of synaptojanin disrupts H5 filaments. Swiss 3T3 cells
were transfected with (a–d) pEGFP alone or with (e–h) pEGFP and
pCDNA-synaptojanin, then processed for immunocytochemistry.
Cells immunostained with an antibody to H5 were detected with
(c,d,g,h) a Cy3-conjugated secondary antibody or with
(a,b,e,f) rhodamine–phalloidin to detect filamentous (F)-actin. The
expression of GFP recombinant proteins for each set is shown to the
left (a,c,e,g). Cells expressing synaptojanin (detected in e,g) had
disruptions to actin and H5 filaments (f,h) not seen in neighboring cells
in the same image.
(a) (b)
(c) (d)
(e) (f)
(g) (h)
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throughout evolution, with similar motifs being found in
septins from yeast to mammals. In the mammalian septins
almost all of the isoforms contain an identical motif. Only
the two uncharacterized mammalian proteins, KIAA0128
[12], and KIAA0202 [13], have poor conservation of this
motif, but these proteins have not yet been shown to have
septin functions and might not be true septins. Alterna-
tively, septins lacking PtdInsP2-binding sites might be
under other forms of regulation.
The septins are unique among proteins containing the
polybasic PtdInsP2-binding motif, in that this site is located
in the proximity of another functional site, the P-loop of the
GTP-binding domain. This proximity raises the prospect
that occupancy of the two sites by their respective ligands
might be in some way interdependent. Indeed, although
we found that GTP binding and hydrolysis by H5 were not
affected by the presence of PtdInsP2 micelles, binding to
the phospholipid was significantly inhibited by the pres-
ence of GTP. The simplest explanation that could account
for this interdependence is that occupancy of one site steri-
cally interferes with occupancy of the other. While the
P-loop interacts with the α- and β-phosphates of the
nucleotide [38], only GTP interfered with the binding of
PtdInsP2. It is therefore conceivable that the γ-phosphate of
GTP extends to the vicinity of the phospholipid-binding
domain, where it could obstruct the interaction with
PtdInsP2. Alternatively, binding of GTP, but not GDP,
could cause a conformational change in H5 that masks or
alters the PtdInsP2-binding site, making it inaccessible.
GTPγS inhibited PtdInsP2 binding less effectively than
GTP, however, indicating that steric interference by the
γ-phosphate is not the principal cause of binding differ-
ences and suggesting that dissociation results as a conse-
quence of conformational changes that occur during the
process of GTP hydrolysis. In this context, it is of interest to
note that PtdInsP2 can stimulate the dissociation of GDP
from the small GTPases Rho, CDC42, and Rac [39], as has
previously been shown for Arf1 [40]. In these cases,
PtdInsP2 is thought to bind to a carboxy-terminal polybasic
region [39] that is remote from the nucleotide-binding site,
suggesting that displacement of GDP is the result of a con-
formational change in the protein.
Preferential binding of PtdInsP2 to the GDP-associated
form of H5 could provide a means by which the location
of the septin within the cell is regulated. Previous
studies of immunoisolated Drosophila and mammalian
septins revealed that they exist as filamentous ‘rodlets’
and that they are predominantly associated with GDP.
The short filaments isolated from Drosophila, and pre-
dicted to comprise a set of the three Drosophila septin
proteins, have a GDP:GTP ratio of about 2.6 [9]. If the
isolated septin complexes are representative of in vivo
septin complexes, this suggests that septin complexes
should have the potential to interact with PtdInsP2
in vivo. Moreover, one study has suggested that GTP
hydrolysis is associated with the filamentous appearance
of septins in mammals [20]. In this study, it was shown
that injection of a non-hydrolyzable GTP analog or trans-
fection of mutant Nedd5 proteins unable to bind GTP
disrupts the filamentous appearance of endogenous
Nedd5 [20]. If mammalian septins exist in higher-order
filaments, as they do in yeast, then it is possible that the
filamentous structures seen by microscopy might reflect
septin polymerization. In such a case, GTP-bound forms
of H5, which in our study did not bind to PtdIns(4,5)P2,
would be unable to bind PtdIns(4,5)P2, whereas GDP-
bound forms in filament-like structures would. Preferen-
tial PtdIns(4,5)P2 binding by the GDP-bound forms
along the filament core could be responsible for the
anchorage and accumulation of filaments at the regions
where PtdIns(4,5)P2 is concentrated.
Continuous interaction of the septin proteins with
PtdIns(4,5)P2 appears to be necessary for the maintenance
of their filamentous appearance. In non-mitotic cells the
H5 protein is normally found in a filamentous pattern
similar to that of actin, but in cells treated with neomycin,
in those transfected with the PtdIns 5-phosphatase synap-
tojanin, or in those treated with ionomycin to activate
phospholipase C, H5 filaments disappeared and punctate
staining was observed. In the former two cases, these
effects correlated with loss of actin filaments, and septin
appearance could have been altered as a consequence of
alterations in actin. In contrast, ionomycin treatment
resulted in a disruption of the H5 filaments that preceded
changes in actin stress fibers, indicating that their filamen-
tous appearance is not solely due to the filamentous
arrangement of actin. If the septins are true filaments,
then their filamentous properties depend on binding to
PtdIns(4,5)P2. Alternatively, if H5 proteins or septin
rodlets simply associate with actin and thereby appear fila-
mentous, then this association is dependent on the contin-
ued presence of PtdIns(4,5)P2. 
Septin function is required for cytokinesis and inhibition
of this function induces the formation of multinucleated
cells. Interestingly, treatment of cells with agents, such
as neomycin, that interfere with PtdInsP2 also altered the
appearance of H5 and inhibited cytokinesis. A high per-
centage of binucleated cells were observed after inter-
ference with PtdInsP2 binding; binucleated cells occurred
very rarely when cells were untreated. Cells that became
binucleated were probably within 2 hours of undergoing
cytokinesis and underwent mitosis without cytokinesis.
Failure to observe increasing numbers of binucleated
cells accumulate upon longer treatment implies that
additional PtdInsP2-dependent steps earlier in the cycle
might also be required for progression into mitosis. Nev-
ertheless, our results raise the possibility that one of the
PtdInsP2-dependent steps late in the cell cycle might be
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the interaction of PtdIns(4,5)P2 with H5, and this might
be involved in the recruitment of septins to the cleavage
furrow,  where they can carry out their essential role in
cell cleavage. 
Materials and methods
PtdInsP2-binding assays
The ELISA procedures for PtdInsP2 binding assays were developed by
Miki et al. [22], and used with some modifications. Briefly, GST, or
GST–H5 fusion proteins or peptides were absorbed to 96-well plates
in 50 ml of bicarbonate buffer (50 mM sodium bicarbonate, pH 9.6) at
1 µg/well and incubated at room temperature for 4 h or overnight at
4°C. After washing three times with PBS, PtdInsP2, resuspended in
PBS, was added to the well at 1 µg per well and incubated at room
temperature for 2 h. After washing three times in PBS, the wells were
blocked with 3% powdered milk dissolved in PBS, washed once in
PBS, and then incubated with primary antibody. Anti-PtdInsP2
(PerSeptive Biosystems) was diluted 1:500 in blocking solution and
incubated for 2 h at room temperature. The wells were again washed
three times and a secondary goat anti-mouse antibody conjugated with
horseradish peroxidase (HRP) was used at a dilution of 1:1000 in 50 µl
PBS and incubated for 1 h at room temperature. After three washes in
PBS, the wells were incubated with 50 µl developing solution contain-
ing orthophosphate diamine as substrate and the absorbance at
450 nm was measured in the ELISA plate reader.
To determine the specificity of lipid interactions, 1 µg of each of the
following phospholipids was coated in the wells of a 96-well plate
and allowed to dry: PtdIns(4,5)P2 (sodium salt, Sigma), PtdIns(4)P
(sodium salt, Sigma), PtdIns (sodium salt, Sigma), PtdSer (Sigma),
and PtdCho (chloroform solution, Sigma). After washing the wells
three times in PBS, they were blocked with milk powder solution, as
above, washed, and incubated with GST or GST–H5 fusion protein
at 1 µg per 50 µl at room temperature for 2 h. After three washes, the
wells were developed as above, this time probing with rabbit anti-
GST antibody followed by a secondary HRP-conjugated goat anti-
rabbit antibody. 
In competition experiments, neomycin sulfate, pentalysine or block-
ing peptides were preincubated with the PtdInsP2 micelles in PBS at
room temperature for 30 min. The mixture (1 µg of each in 50 µl) was
then added to the protein-coated wells and developed as above.
Synthetic peptides (Sheldon Biotechnology) were produced: the first
was of a region that included the polybasic motif of H5 and was
identical to amino acids 136–149 (PEP1, sequence Ac-
RKSVKKGFDFTLMVC-NH2); the second was a control peptide
(PEP2) generated from the amino-terminus amino acids 26–45 of H5
(Ac-EDSSDDDAELSKFVKDFPGC-NH2). 
Liposome sedimentation assays were performed as follows. Lipid
vesicles comprising 95% PtdCho and 5% of either PtdIns(3,4)P2,
PtdIns(4,5)P2 or PtdIns(3,4,5)P3 were prepared as described by
Kubiseki et al. [23]. Briefly, the lipids were mixed in buffer containing
10 mM HEPES pH 7.0 and 10 mM sucrose, vortexed for 1 min, then
subjected to five freeze–thaw cycles on dry ice. Liposomes were
then used immediately by mixing with 1 µg H5 protein and incubating
at room temperature with shaking for 1 h. Liposomes were then pel-
leted by centrifugation at 50,000 × g for 40 min at 25°C. The resul-
tant supernatants and pellets were analyzed by SDS–PAGE and
western blotting with anti-H5 antibody. Relative H5 levels were
determined from densitometric scans of linear exposures from three
independent experiments.
Deletion constructs of H5 and site-directed mutagenesis
Four carboxy-terminal truncations were produced in H5 using the bac-
terial expression vector pGEX, as follows: D452 was generated by
partial digestion of pGEX-H5 with HindIII, which cleaved at nucleotide
1356 after the initiation methionine and 3′ to the cDNA in the
pGEX-KG vector. D363 was produced by cleavage with SalI, which
cleaved at nucleotide 1089 and in the vector 3′ of the insert. D230
was generated by cutting the insert with BclI and cutting pGEX-KG
with XhoI, followed by blunt-ending with Klenow and ligation. D112
was produced with a complete HindIII digestion by cleavage at
nucleotide 336 and in the pGEX-KG polylinker.
Site-directed mutagenesis was performed by using the QuickChange
Kit (Stratagene) following the manufacturer’s recommendations.
PGEX-H5 DNA was used as template and the following two pairs of
mutagenic oligonucleotides were used: P1A, 5′-CCCAACCAAGTC-
CACGCAGCGTCCGTGAAGAAAGGC-3′; P1B, 5′-GCCTTTCTT-
CACGGACGCTGCGTGGACTTGGTTGGG-3′; P2A, 5′-CACCGA-
AAGTCCGTGGCGGCAGGCTTTGCATTTACC-3′; P2B, 5′-GGT-
AAAGTCAAAGCCTGCCGCCACGGACTTTCGGTG-3′.
Assays of GTP binding and hydrolysis
Extracts of bacteria expressing either GST or GST–H5 were purified
on glutathione–agarose beads and left bound to the beads for GTP-
binding assays. The GTP-binding and -hydrolysis assays were per-
formed as described by Kinoshita et al. [20], with slight modification.
Briefly, beads containing 0.5 µg or 1 µg GST–H5 were incubated with
1 µg PtdInsP2 at 4°C overnight in PBS. The beads were then washed
in PBS before incubation with 10 nM [γ-32P]GTP in GTP-binding
buffer containing 20 mM Tris–HCl pH 8.0, 5 mM MgCl2, 100 mM
NaCl, 10 mM 2-mercaptoethanol, 10% glycerol, 5 mM EDTA and
100 µg/ml bovine serum albumin. The binding was performed for
20 min at 4°C. Hydrolysis was assayed by first washing the beads
three times in binding buffer at 4°C before the buffer was exchanged
with 50 µl reaction buffer (binding buffer lacking EDTA) and incuba-
tion for 0, 5 or 20 min at 37°C. The reaction was stopped by washing
the beads with the same buffer and the radioactivity bound to the
beads was determined by counting in scintillation fluid. The amount of
[γ-32P]GTP remaining bound to the beads after three washes in the
same buffer was the bound fraction and loss of radioactivity on the
beads reflected the hydrolysis of GTP. Control experiments involved
the incubation of the beads at 37°C but in the presence of EDTA and
in this case, little radioactivity was lost from the beads. Experiments
were performed in quadruplicate.
Cell culture and experimental treatments
Swiss 3T3 cells, obtained from the ATCC, were grown on coverslips to
60% confluence in DMEM containing 10% fetal calf serum (FCS) at
37°C. For neomycin treatments, cells grown as above were incubated for
2–24 h in 5 mM neomycin sulfate in DMEM + 10% FCS. Transfections
were performed essentially as described [41]. After 48 h, the cells were
fixed and processed for immunocytochemistry. For the synaptojanin-
expression construct, the 5′ end of a synaptojanin cDNA [42] was ligated
to a partial synaptojanin cDNA construct [43] (a gift of Rudiger Woschol-
ski and Peter Parker, Imperial Cancer Research Fund, London) at a
unique NheI site. The complete cDNA clone was then subcloned into the
mammalian expression vector pcDNA 3.1 at the EcoRI site. Transfections
were carried out either with the pEGFP vector (Clontech) alone, or with a
mixture of pEGFP and pCDNA3.1 synaptojanin.
For ionomycin treatments, cells were transfected with a vector encoding a
fusion construct comprising the phospholipase C-δ PH domain and GFP
[37] and cultured on coverslips in Dulbecco’s MEM overnight, then incu-
bated in the same medium (containing 1.7 mM Ca2+) in the presence of
2 µM ionomycin (Calbiochem) for 10 min at room temperature. The cells
were then immediately fixed and processed for immunocytochemistry. 
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